{"id":14515,"date":"2023-02-24T16:13:35","date_gmt":"2023-02-24T09:13:35","guid":{"rendered":"https:\/\/hpsp-prod.th1.proen.cloud\/%e0%b8%a1%e0%b8%b0%e0%b9%80%e0%b8%a3%e0%b9%87%e0%b8%87%e0%b9%81%e0%b8%9e%e0%b8%a3%e0%b9%88%e0%b8%81%e0%b8%a3%e0%b8%b0%e0%b8%88%e0%b8%b2%e0%b8%a2%e0%b9%84%e0%b8%9b%e0%b8%81%e0%b8%a3%e0%b8%b0%e0%b8%94\/"},"modified":"2023-03-06T15:33:03","modified_gmt":"2023-03-06T08:33:03","slug":"bone-metastasis","status":"publish","type":"post","link":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/","title":{"rendered":"Bone Metastasis"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<\/p>\n<h1><strong>Our clinical trial : Bone metastasis<\/strong><\/h1>\n<p><span style=\"font-weight: 400;\">Trial status: recruiting<\/span><\/p>\n<p><span style=\"font-weight: 400;\">First posted: 30 January 2023<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Last updated: 30 January 2023<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Full Title<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Randomised trial comparing single fraction of proton stereotactic body radiotherapy (SBRT) versus 3 fractions of photon SBRT for bone metastatic patients <\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1678087981962{background-color: #eff3fa !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<strong>Purpose<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Due to the accuracy of the proton beam and the paucity of data, treating bone metastases with proton SBRT would be practically challenging. We aim to assess whether proton SBRT can be successfully given to those with bone metastases, and we will compare whether pain control (either complete or partial pain control) is not inferior with proton SBRT in bone metastases patients as compared to photon SBRT.<\/span>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;14957&#8243; img_size=&#8221;full&#8221; style=&#8221;vc_box_shadow_border&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<strong>Eligibility<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">To be eligible for this study, patients must meet following requirements, including:<\/span><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Patients with a pathologic diagnosis of malignancy<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients who are over 18 years old.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients with any radiographic evidence of bone metastases, including<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">plain x-ray, bone scan, CT scan, MRI scan, or PET scan<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients with a life expectancy of more than 3 months<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients with solitary, oligometastatic, or bone-only metastatic disease<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients who are able to complete the NRPS scores and the questionnaire on quality of life<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients with no more than three separate radiation treatment fields concurrently<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients undergoing surgery for osseous metastases are allowed.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients with gross residual disease or a high risk for recurrence after surgery\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients who have already been treated with conventional beam radiation therapy at the treatment site (more than 90 days ago)<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Patients with spinal cord compression after decompressive surgery<\/span><\/li>\n<\/ul>\n<p><strong>Phase : <\/strong><span style=\"font-weight: 400;\">II\/III<\/span><\/p>\n<p><strong>Disease Status : <\/strong><span style=\"font-weight: 400;\">Advanced stage (Bone metastatic disease)<\/span><\/p>\n<p><strong>Investigator : <\/strong><span style=\"font-weight: 400;\">Kitwadee Saksornchai<\/span><\/p>\n<p><strong>Co-Investigators<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Napapat Amornwichet<\/span><\/li>\n<li>Kanjana Shotelersak<\/li>\n<\/ul>\n<p><strong>Diseases : <\/strong><span style=\"font-weight: 400;\">Cancer , bone metastatic disease<\/span><\/p>\n<p><strong>Locations : <\/strong><span style=\"font-weight: 400;\">King Chulalongkorn Memorial hospital<\/span>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] Our clinical trial : Bone metastasis Trial status: recruiting First posted: 30 January 2023 Last updated: 30 January 2023 &nbsp; Full Title Randomised trial comparing single fraction of proton stereotactic body radiotherapy (SBRT) versus 3 fractions of photon SBRT for bone metastatic patients [\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1678087981962{background-color: #eff3fa !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]Purpose Due to the accuracy<\/p>\n","protected":false},"author":1,"featured_media":14957,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[174],"tags":[],"type_post":[],"class_list":["post-14515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bone Metastasis - HPSP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bone Metastasis - HPSP\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text] Our clinical trial : Bone metastasis Trial status: recruiting First posted: 30 January 2023 Last updated: 30 January 2023 &nbsp; Full Title Randomised trial comparing single fraction of proton stereotactic body radiotherapy (SBRT) versus 3 fractions of photon SBRT for bone metastatic patients [\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1678087981962{background-color: #eff3fa !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]Purpose Due to the accuracy\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/\" \/>\n<meta property=\"og:site_name\" content=\"HPSP\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-24T09:13:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-06T08:33:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hpsp.or.th\/wp-content\/uploads\/2023\/02\/\u0e21\u0e30\u0e40\u0e23\u0e47\u0e07\u0e41\u0e1e\u0e23\u0e48\u0e01\u0e23\u0e30\u0e08\u0e32\u0e22\u0e44\u0e1b\u0e01\u0e23\u0e30\u0e14\u0e39\u0e01.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"hpsp.or.th@gmail.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hpsp.or.th@gmail.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/\"},\"author\":{\"name\":\"hpsp.or.th@gmail.com\",\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/person\/94efc677e81b8adf6e71004bb9029e7b\"},\"headline\":\"Bone Metastasis\",\"datePublished\":\"2023-02-24T09:13:35+00:00\",\"dateModified\":\"2023-03-06T08:33:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/\"},\"wordCount\":347,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/hpsp.or.th\/#organization\"},\"articleSection\":[\"research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/\",\"url\":\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/\",\"name\":\"Bone Metastasis - HPSP\",\"isPartOf\":{\"@id\":\"https:\/\/hpsp.or.th\/#website\"},\"datePublished\":\"2023-02-24T09:13:35+00:00\",\"dateModified\":\"2023-03-06T08:33:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hpsp.or.th\/en\/bone-metastasis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hpsp.or.th\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bone Metastasis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hpsp.or.th\/#website\",\"url\":\"https:\/\/hpsp.or.th\/\",\"name\":\"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c\",\"description\":\"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c \u0e2a\u0e20\u0e32\u0e01\u0e32\u0e0a\u0e32\u0e14\u0e44\u0e17\u0e22\",\"publisher\":{\"@id\":\"https:\/\/hpsp.or.th\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hpsp.or.th\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hpsp.or.th\/#organization\",\"name\":\"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c\",\"url\":\"https:\/\/hpsp.or.th\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hpsp-prod.th1.proen.cloud\/wp-content\/uploads\/2023\/03\/HPSP-Social-Share.jpg\",\"contentUrl\":\"https:\/\/hpsp-prod.th1.proen.cloud\/wp-content\/uploads\/2023\/03\/HPSP-Social-Share.jpg\",\"width\":1200,\"height\":630,\"caption\":\"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c\"},\"image\":{\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/person\/94efc677e81b8adf6e71004bb9029e7b\",\"name\":\"hpsp.or.th@gmail.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/38dca655bf214dcfdab92db73d7ba6f43a3a77af390e23fbf7c59d604aa6be67?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/38dca655bf214dcfdab92db73d7ba6f43a3a77af390e23fbf7c59d604aa6be67?s=96&d=mm&r=g\",\"caption\":\"hpsp.or.th@gmail.com\"},\"sameAs\":[\"https:\/\/hpsp-or-th.th1.proen.cloud\"],\"url\":\"https:\/\/hpsp.or.th\/en\/author\/hpsp-or-thgmail-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bone Metastasis - HPSP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/","og_locale":"en_US","og_type":"article","og_title":"Bone Metastasis - HPSP","og_description":"[vc_row][vc_column][vc_column_text] Our clinical trial : Bone metastasis Trial status: recruiting First posted: 30 January 2023 Last updated: 30 January 2023 &nbsp; Full Title Randomised trial comparing single fraction of proton stereotactic body radiotherapy (SBRT) versus 3 fractions of photon SBRT for bone metastatic patients [\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1678087981962{background-color: #eff3fa !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]Purpose Due to the accuracy","og_url":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/","og_site_name":"HPSP","article_published_time":"2023-02-24T09:13:35+00:00","article_modified_time":"2023-03-06T08:33:03+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/hpsp.or.th\/wp-content\/uploads\/2023\/02\/\u0e21\u0e30\u0e40\u0e23\u0e47\u0e07\u0e41\u0e1e\u0e23\u0e48\u0e01\u0e23\u0e30\u0e08\u0e32\u0e22\u0e44\u0e1b\u0e01\u0e23\u0e30\u0e14\u0e39\u0e01.jpg","type":"image\/jpeg"}],"author":"hpsp.or.th@gmail.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"hpsp.or.th@gmail.com","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/#article","isPartOf":{"@id":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/"},"author":{"name":"hpsp.or.th@gmail.com","@id":"https:\/\/hpsp.or.th\/#\/schema\/person\/94efc677e81b8adf6e71004bb9029e7b"},"headline":"Bone Metastasis","datePublished":"2023-02-24T09:13:35+00:00","dateModified":"2023-03-06T08:33:03+00:00","mainEntityOfPage":{"@id":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/"},"wordCount":347,"commentCount":0,"publisher":{"@id":"https:\/\/hpsp.or.th\/#organization"},"articleSection":["research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hpsp.or.th\/en\/bone-metastasis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/","url":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/","name":"Bone Metastasis - HPSP","isPartOf":{"@id":"https:\/\/hpsp.or.th\/#website"},"datePublished":"2023-02-24T09:13:35+00:00","dateModified":"2023-03-06T08:33:03+00:00","breadcrumb":{"@id":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hpsp.or.th\/en\/bone-metastasis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hpsp.or.th\/en\/bone-metastasis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hpsp.or.th\/en\/"},{"@type":"ListItem","position":2,"name":"Bone Metastasis"}]},{"@type":"WebSite","@id":"https:\/\/hpsp.or.th\/#website","url":"https:\/\/hpsp.or.th\/","name":"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c","description":"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c \u0e2a\u0e20\u0e32\u0e01\u0e32\u0e0a\u0e32\u0e14\u0e44\u0e17\u0e22","publisher":{"@id":"https:\/\/hpsp.or.th\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hpsp.or.th\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hpsp.or.th\/#organization","name":"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c","url":"https:\/\/hpsp.or.th\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hpsp.or.th\/#\/schema\/logo\/image\/","url":"https:\/\/hpsp-prod.th1.proen.cloud\/wp-content\/uploads\/2023\/03\/HPSP-Social-Share.jpg","contentUrl":"https:\/\/hpsp-prod.th1.proen.cloud\/wp-content\/uploads\/2023\/03\/HPSP-Social-Share.jpg","width":1200,"height":630,"caption":"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c"},"image":{"@id":"https:\/\/hpsp.or.th\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/hpsp.or.th\/#\/schema\/person\/94efc677e81b8adf6e71004bb9029e7b","name":"hpsp.or.th@gmail.com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hpsp.or.th\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/38dca655bf214dcfdab92db73d7ba6f43a3a77af390e23fbf7c59d604aa6be67?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/38dca655bf214dcfdab92db73d7ba6f43a3a77af390e23fbf7c59d604aa6be67?s=96&d=mm&r=g","caption":"hpsp.or.th@gmail.com"},"sameAs":["https:\/\/hpsp-or-th.th1.proen.cloud"],"url":"https:\/\/hpsp.or.th\/en\/author\/hpsp-or-thgmail-com\/"}]}},"_links":{"self":[{"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/posts\/14515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/comments?post=14515"}],"version-history":[{"count":6,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/posts\/14515\/revisions"}],"predecessor-version":[{"id":15401,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/posts\/14515\/revisions\/15401"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/media\/14957"}],"wp:attachment":[{"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/media?parent=14515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/categories?post=14515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/tags?post=14515"},{"taxonomy":"type_post","embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/type_post?post=14515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}